| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 1.21e-02 | 271 | 9 | 2 | MM15406 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 1.36e-02 | 288 | 9 | 2 | M16864 | |
| Coexpression | GSE26559_TCF1_KO_VS_WT_LIN_NEG_CELL_UP | 6.70e-05 | 198 | 11 | 3 | M8423 | |
| Coexpression | GSE17721_CTRL_VS_CPG_24H_BMDC_UP | 6.90e-05 | 200 | 11 | 3 | M3771 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.37e-05 | 199 | 11 | 3 | 565404c155dfac57c020a8f2d09cbf756da20ffd | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Erythro-Megakary|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.37e-05 | 199 | 11 | 3 | 6c174dbcc25b980f10a3d1dfe39e613acac73bb6 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.37e-05 | 199 | 11 | 3 | 284ee9632413f6404fc0b0c7c393ad813db834f2 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.80e-04 | 148 | 11 | 2 | 80470353e12599440f711b6e107730763376d04d | |
| ToppCell | B_cells-ABCs|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 7.11e-04 | 164 | 11 | 2 | f45013706a917f0f0d69c23f288128f252cd60c7 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_activated|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.54e-04 | 169 | 11 | 2 | 2098f15a388d019ed7f1d4c209affd5ca2886dcc | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.63e-04 | 170 | 11 | 2 | d9ed257d0938442d0bb280e4c4b0c9b657511b46 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-migDC|lymph-node_spleen / Manually curated celltypes from each tissue | 7.81e-04 | 172 | 11 | 2 | 1b24bed3cd8e3fa463c5e7cefdf9e99e639e2f84 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 7.90e-04 | 173 | 11 | 2 | efb8072475000888efe088d00e870c56ffad4172 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-Promyelocyte-like|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.99e-04 | 174 | 11 | 2 | 1c0c04c37bfdbdb47bda57784734e0c5f1e8ed87 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.99e-04 | 174 | 11 | 2 | 58300d64d3b6fd9ba1b6c87ea83b2777eb6be2f4 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 8.18e-04 | 176 | 11 | 2 | 8513c2a05a34453a16bbcf1c11cb34c580133e47 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.27e-04 | 177 | 11 | 2 | 68f1139fc378f351e3b9e9f392aacb150025bf03 | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-1|390C / Donor, Lineage, Cell class and subclass (all cells) | 8.46e-04 | 179 | 11 | 2 | e7045e27f0eb88f552b31c04b56d78e5ccd7a36c | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.46e-04 | 179 | 11 | 2 | 3edcd1356e49b1f5514c585861999e079ca5e579 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c06-MKI67|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.64e-04 | 181 | 11 | 2 | c18e5a3f5d99043fa3cb33e2ac33fa98cd15d3db | |
| ToppCell | IIH-Treg-proli_CD4|IIH / Condition, Cell_class and T cell subcluster | 8.74e-04 | 182 | 11 | 2 | 5c7d02da9ca2bca49db9832704b6894dfaa08a71 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-Lymphoid_DC|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.83e-04 | 183 | 11 | 2 | 9ca4954faaba50466c35121d6765895e955178aa | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-SST-MGE1-3|World / Primary Cells by Cluster | 8.93e-04 | 184 | 11 | 2 | 907ba412166bcb0526c5be0b06a76b6bd37c5a35 | |
| ToppCell | Fetal_29-31_weeks-Immune-enucleated_erythrocyte-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.03e-04 | 185 | 11 | 2 | c4bf3ac684c1a8876b51f7af4d3a62dc47e961ee | |
| ToppCell | Immune-enucleated_erythrocyte|World / Lineage, Cell type, age group and donor | 9.12e-04 | 186 | 11 | 2 | f9d5ec5cc8fd6e63bf25abe390307ec8a4a2d5a3 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.32e-04 | 188 | 11 | 2 | 3139540a656c0436b2123ea50741ff8d00112165 | |
| ToppCell | Fetal_29-31_weeks-Immune-enucleated_erythrocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.42e-04 | 189 | 11 | 2 | 1900e574870fc647bfa11c732a72f3d38aab717c | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Activated_DCs|normal_Lymph_Node / Location, Cell class and cell subclass | 9.52e-04 | 190 | 11 | 2 | 15978ddd37b521343f88b62dad1643077fc22b2b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.52e-04 | 190 | 11 | 2 | 56cc761e50fddfb5366391518b4d8e16589b6b42 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.52e-04 | 190 | 11 | 2 | 25d4b591f75c26e404a34c42f1742d580af6598d | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_B-ABC_aged-B_memory|lymph-node_spleen / Manually curated celltypes from each tissue | 9.62e-04 | 191 | 11 | 2 | c3ca8077da8594fb493e47ac4dfbbd20bfc14b37 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.82e-04 | 193 | 11 | 2 | 305e15ee467826ee08b2617c69f250ad39c11b19 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.82e-04 | 193 | 11 | 2 | dd376664906caccc9c2065f8e7a364509e18a5cc | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.01e-03 | 196 | 11 | 2 | de70cc301a8cbaedb0a5ea4a6442dcdaa477822d | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.03e-03 | 198 | 11 | 2 | cc2b5b632e73e44bb60050f0db10d8f0dbb859fa | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.04e-03 | 199 | 11 | 2 | 26bb93347e6722abd174dfa62cab692ce2b7eb23 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.05e-03 | 200 | 11 | 2 | a372ef3f9e6ff6e3c3376d6e10182977c5067788 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Erythro-Megakary|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.05e-03 | 200 | 11 | 2 | d85074b362b11e5a523a5325d203a61aa2759a7a | |
| ToppCell | LPS_IL1RA-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.05e-03 | 200 | 11 | 2 | fa1eaf008b54bdf7bbcdec8134460c5f64490de9 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Erythro-Megakary-Erythro-Mega|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.05e-03 | 200 | 11 | 2 | f99e214eb680fd82a33f2b1524fbfca265d1cc42 | |
| Drug | isoxaflutole | 2.54e-05 | 16 | 11 | 2 | CID000084098 | |
| Drug | Butylparaben [94-26-8]; Down 200; 20.6uM; PC3; HT_HG-U133A | 9.13e-05 | 191 | 11 | 3 | 4647_DN | |
| Drug | Zomepirac sodium salt [64092-48-4]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 9.56e-05 | 194 | 11 | 3 | 3454_DN | |
| Drug | Articaine hydrochloride [23964-57-0]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 1.00e-04 | 197 | 11 | 3 | 6517_DN | |
| Drug | Piperacetazine [3819-00-9]; Down 200; 9.8uM; PC3; HT_HG-U133A | 1.00e-04 | 197 | 11 | 3 | 5834_DN | |
| Drug | Sulfanilamide [63-74-1]; Down 200; 23.2uM; MCF7; HT_HG-U133A | 1.02e-04 | 198 | 11 | 3 | 3449_DN | |
| Drug | Moxisylyte hydrochoride [964-52-3]; Up 200; 12.6uM; PC3; HT_HG-U133A | 1.03e-04 | 199 | 11 | 3 | 1804_UP | |
| Disease | melanoma | 9.70e-04 | 126 | 11 | 2 | EFO_0000756 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.41e-03 | 152 | 11 | 2 | DOID:0060041 (implicated_via_orthology) | |
| Disease | cortical thickness | 7.04e-03 | 1113 | 11 | 3 | EFO_0004840 | |
| Disease | 3-hydroxy-1-methylpropylmercapturic acid measurement | 7.27e-03 | 352 | 11 | 2 | EFO_0007015 | |
| Disease | Mammary Neoplasms, Human | 1.56e-02 | 525 | 11 | 2 | C1257931 | |
| Disease | Mammary Carcinoma, Human | 1.56e-02 | 525 | 11 | 2 | C4704874 | |
| Disease | Mammary Neoplasms | 1.57e-02 | 527 | 11 | 2 | C1458155 | |
| Disease | Breast Carcinoma | 1.64e-02 | 538 | 11 | 2 | C0678222 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LLDDQHWHSVLIQRL | 266 | Q9C0A0 | |
| LQQGDWRLQQLHLQH | 441 | Q9NSY1 | |
| QINRHWHDVLQQLLL | 321 | Q96Q35 | |
| LWLHALHLRQKGNRN | 366 | Q9UK73 | |
| LHLWNNGRNHLIFNL | 181 | Q16394 | |
| AAQLQHLWRLLLLNQ | 561 | Q9NTJ4 | |
| HLWRLLLLNQFHDVV | 566 | Q9NTJ4 | |
| SRQIQLWHFILELLQ | 36 | Q6ZN32 | |
| LLLFQFAHHLELWRL | 346 | Q969X6 | |
| LLQLDIRHLWNHSII | 176 | Q15021 | |
| HELVLWIQQNLRHIL | 101 | Q9Y3V2 | |
| LLLQQQRLGRALWHL | 91 | Q6ZTW0 |